1 year return (CAGR)
30.77%
Avalo Therapeutics Inc Exchange (NASDAQ, USD)
AVTX
15.30
-1.21 (-7.33%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-19.67%
5 year return (CAGR)
-70.33%
10 year return (CAGR)
-48.25%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
820.54M
Price/Sales
13907.44
Ent value
777.28M
Price/Book
1.83
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-70.18%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 16.40 |
| Daily high | 16.48 |
| Daily low | 15.13 |
| Daily Volume | 1.11M |
| All-time high | 20793.60 |
| 1y analyst estimate | 44.15 |
| Beta | 0.79 |
| EPS (TTM) | -2.30 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| AVTX | S&P500 | |
| Current price drop from All-time high | -99.93% | -1.29% |
| Highest price drop | -99.98% | -56.47% |
| Date of highest drop | 28 May 2025 | 9 Mar 2009 |
| Avg drop from high | -71.76% | -10.68% |
| Avg time to new high | 547 days | 12 days |
| Max time to new high | 1904 days | 1805 days |
News
